• Aucun résultat trouvé

Melatonin Levels in Preterm and Term Infants and Their Mothers

N/A
N/A
Protected

Academic year: 2022

Partager "Melatonin Levels in Preterm and Term Infants and Their Mothers"

Copied!
5
0
0

Texte intégral

(1)

Article

Reference

Melatonin Levels in Preterm and Term Infants and Their Mothers

BIRAN, Valérie, et al.

Abstract

The prevention of perinatal brain damage following preterm birth remains a public health priority. Melatonin has been shown to be a promising neuroprotectant in neonatal preclinical models of brain damage, but few studies have investigated melatonin secretion in newborns.

We hypothesized that melatonin circulating levels would be lower in preterm compared to term infants. We conducted a prospective, longitudinal, multicenter study to assess melatonin, and 6-sulfatoxy-melatonin (aMT6s) concentrations, measured by radioimmunoassay. Among 209 neonates recruited, 110 were born before 34 gestational weeks (GW) and 99 born after 34 GW. Plasma melatonin concentrations, measured at birth and on Day 3 were below detectable levels (≤7 pg/mL) in 78% and 81%, respectively, of infants born before 34 GW compared to 57% and 34%, respectively, of infants born after 34 GW. The distribution of plasma melatonin concentrations was found to be correlated with gestational age at both time-points (p < 0.001). Median urine aMT6s concentrations were significantly lower in infants born before 34 GW, both on Day 1 (230 ng/L vs. 533 ng/L, p < [...]

BIRAN, Valérie, et al . Melatonin Levels in Preterm and Term Infants and Their Mothers.

International Journal of Molecular Sciences , 2019, vol. 20, no. 9, p. 2077

DOI : 10.3390/ijms20092077 PMID : 31035572

Available at:

http://archive-ouverte.unige.ch/unige:137429

Disclaimer: layout of this document may differ from the published version.

1 / 1

(2)

Supplemental Figures and Tables

Supplemental Figure S1: Flowchart of patient recruitment in the two gestational age groups (240/7- 336/7 weeks and 340/7- 416/7 weeks).

(3)

Supplemental Table S1: Baseline characteristics of infants and their mothers according to gestational age groups.

Variable Gestational age group

240/7- 336/7 GW 340/7- 416/7 GW

Mothers N=88 N=81

Race or ethnic group - N (%) Caucasian

African Asian Other

47 (54%) 36 (41%) 2 (2%) 2 (2%)

29 (39%) 41 (55%) 3 (4%) 2 (3%) Gestation

Median (1st quartile – 3rd quartile – IQR) Min ; Max

2 (2 – 4) 1 ; 9

2 (2 – 4) 1 ; 7 Parity

Median (IQR) Min ; Max

2 (1 – 3) 1 ; 7

2 (1 – 3) 1 ; 7

Pre-eclampsia - N (%) 9 (10%) 1 (1%)

Antenatal glucocorticoid treatment - N (%) 73 (89%) 12 (22%)

Vaginal delivery - N (%) 48 (55%) 65 (81%)

Epidural analgesia - N (%) 31 (65%) 58 (89%)

Infants N=110 N=99

Gestational age - weeks Median (IQR)

Min ; Max

28·1 (26·6 – 31·3) 24·0 ; 33·4

37·9 (35·6 – 39·9) 34·0 ; 41·9

Male sex - N (%) 61 (55%) 42 (42%)

Birth weight - g Median (IQR)

Min ; Max

1128 (820 – 1500) 443 ; 2420

2615 (2285 – 3340) 1300 ; 4370 Birth head circumference - cm

Median (IQR) Min ; Max

26·5 (23·5 – 28,5) 2.0 ; 34·5

33·0 (32·0 – 35·0) 27·5 ; 37·0 Birth length - cm

Median (IQR) Min ; Max

37·0 (34·0 – 4.0) 24·5 ; 46·0

47·0 (45·0 – 5.0) 38·0 ; 54·0 Intrauterine growth restriction below 3rd perc.. - N (%) 8 (7%) 7 (7%)

Apgar score at 5 min Median (IQR)

Min ; Max

9 (8 – 10) 0 ; 10

10 (10 – 10) 7 ; 10

Multiple birth - N (%) 42 (38%) 36 (36%)

Phototherapy - N (%) Continuous Discontinuous

79 (76%) 27 (34%) 52 (66%)

30 (31%) 13 (43%) 17 (57%) GW denotes gestational weeks; IQR denotes interquartile range (Q1-Q3).

(4)

Supplemental Table S2: Number of samples (plasma, urine, milk) in mothers and infants according to gestational age group.

240/7 – 336/7 GW 340/7 – 416/7 GW

Mothers N=88 N=81

Plasma Milk Plasma Milk

Delivery N=77 N=75

Day 3 N=37 N=61

Day 10 N=32

Day 25 N=20

Day 55 N=10

Newborn N=110 N=99

Plasma Urine Plasma Urine

Birth N=81 N=86

Day 1 N=97 N=62

Day 3 N=90 N=104 N=83 N=63

Day 10 N=85 N=92

Day 25 N=73 N=82

Day 55 N=47 N=49

GW denotes gestational weeks .

Supplemental Table S3: Comparison of plasma melatonin concentrations (in pg/mL) in mother, and newborn at birth (Day 0) between the 2 gestational age groups and according to delivery time.

Sample 240/7- 336/7 GW 340/7- 416/7 GW P-value*

Mother at delivery Total Median (IQR)

Min ; Max

N=77 7 (7 – 20)

7 ; 213

N=75 11 (7 – 50)

7 ; 158

.02

Nighttime (00:00 – 07:59) Median (IQR)

Min ; Max

N=14 7 (7 – 42)

7 ; 190

N=17 11 (7 – 72)

7 ; 158

.32 Daytime (08:00 – 23:59)

Median (IQR) Min ; Max

N=60 7 (7 – 19)

7 ; 213

N=58 11 (7 – 36)

7 ; 154

.07 Newborn at birth (day 0)

Total Median (IQR)

Min ; Max

N=81 7 (7 – 7)

7 ; 83

N=86 7 (7 – 24)

7 ; 184

.02 Nighttime (00:00 – 07:59)

Median (IQR) Min ; Max

N=15 7 (7 – 15)

7 ; 58

N=22 27 (7 – 73)

7 ; 184

.07 Daytime (08:00 – 23:59)

Median (IQR) Min ; Max

N=66 7 (7 – 7)

7 ; 83

N=64 7 (7 – 11)

7 ; 83

.11

* Wilcoxon-Mann-Whitney test. GW denotes gestational weeks; IQR denotes interquartile range.

Supplemental Table S4: Milk melatonin concentrations (in pg/mL) on Day 3 in the mothers of both gestational age groups and on Days 10, 25 and 55 in mothers who delivered at 240/7- 336/7 weeks.

Time of sampling 240/7- 336/7 GW 340/7- 416/7 GW P-value*

(5)

Day 3 Median (IQR)

Min ; Max

N=22 20 (7 – 33)

7 ; 137

N=53 8 (7 – 16)

7 ; 98

.01 Day 10

Median (IQR) Min ; Max

N=21 16 (7 – 25)

7 ; 93

- - Day 25

Median (IQR) Min ; Max

N=9 19 (7 – 22)

7 ; 48

- - Day 55

Median (IQR) Min ; Max

N=4 20 (15 – 28)

15 ; 31

- -

* Wilcoxon-Mann-Whitney test. GW denotes gestational weeks; IQR denotes interquartile range (Q1-Q3).

Supplemental Table S5: Univariate analysis of plasma melatonin and urine 6-sulfatoxy- melatonin concentrations in neonates according to perinatal variable.

Sample Serum

Melatonin

Urine 6-sulfatoxy- melatonin

Variable Birth Day 3 Day 1

Lower gestational age group (240/7 – 336/7 weeks) – P value .14 <.001 <.001

Male sex – P-value NS NS NS

Multiple gestation – P-value NS .003 NS

Plasma Melatonin concentration ≤7 pg/mL in mother at delivery

– P-value .03 .17 .10

Plasma Melatonin concentration ≤7 pg/mL in newborn at birth –

P-value - NS NS

Pre-eclampsia – P-value NS .04 NS

Intrauterine growth restriction <3 perc. – P-value NS NS NS

Phototherapy – P-value NS <.001 .08

Vaginal delivery – P-value NS .09 .19

Epidural analgesia – P-value .09 NS NS

Serum sampling timing (00:00-05:59) – P-value .04 NS - Urinary sampling timing (20:00-07:59) – P-value - <.001 NS

NS denotes not statistically significant.

Références

Documents relatifs

By means of respiratory inductance plethysmogra- phy (RIP), Elgellab et al.report in this issue of Intensive Care Medicine [21], that nasal CPAP decreases thoraco- abdominal

Magnesium Levels at Birth in Neonates without Magnesium Supplementation during Pregnancy Reference ranges for sMg levels in preterm infants are difficult to pinpoint because a

In this EPIPAGE-2 study, rates of death and severe grades III to IV IVH, a secondary end point, were reduced among infants born after preterm labor and whose mothers received

At discharge, the length of hospitalization had a significant effect on IBHQ worries and distress, fear for future, guilt and impact on daily organization scores (p&lt;0.01);

At the multivariate analysis the signifi- cant risk factors for metabolic acidosis were: gestational age, initial base excess, amino acid and lipid intravenous

The 2 main objectives of this secondary analysis were to define nomograms of cortisol values in serum within the first day of postnatal life according to sex in this high-risk

The main aims of this study were to investigate how mothers’ interventions through vocalisations (speaking and singing), compared with a control condition without the mother,

Conclusions Early hydrocortisone exposure in extremely preterm infants is not statistically associated with either WM brain damage or overall moderate- to- severe brain lesions